Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
20.0%
% of XLV's 60 holdings also in HART
18.2%
% of HART's 75 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus HART)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in HART |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.3% | 5.4% | 5.4% |
|
JOHNSON & JOHNSON | 7.5% | 5.3% | 5.3% |
|
ABBOTT LABORATORIES | 4.3% | 5.7% | 4.3% |
|
BOSTON SCIENTIFIC CORP | 2.8% | 5.4% | 2.8% |
|
PFIZER INC | 2.7% | 5.0% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to HART
|
UNITEDHEALTH GROUP INC | 9.0% |
|
ELI LILLY & CO | 6.9% |
|
ABBVIE INC | 6.9% |
|
MERCK & CO. INC. | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
INTUITIVE SURGICAL INC | 3.3% |
|
AMGEN INC | 3.1% |
|
GILEAD SCIENCES INC | 2.6% |
|
DANAHER CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
XLV Underweight Relative to HART
 |
ASTRAZENECA PLC | -5.6% |
 |
NOVARTIS AG | -5.3% |
|
ALPHABET INC. CLASS A | -5.0% |
|
APPLE INC | -4.9% |
 |
SANOFI-AVENTIS | -4.0% |
 |
NOVO NORDISK A/S-B | -4.0% |
 |
MEDTRONIC PLC | -3.2% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |
|
NIKE INC -CL B | -2.7% |
|
BOSTON SCIENTIFIC CORP | -2.6% |